# ROFLUMILAST
> **ANDA208236** · Abbreviated New Drug Application (Generic) · Sponsor: SENORES PHARMS · Approved 2018-10-03
## Drug
- **FDA Application Number:** ANDA208236
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROFLUMILAST
- **Generic name:** ROFLUMILAST
- **Active ingredients:** ROFLUMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SENORES PHARMS
- **Manufacturer:** Jubilant Cadista Pharmaceuticals Inc.
- **First approval:** 2018-10-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208236)
---
*AI Analytics · CC0 1.0*